132 related articles for article (PubMed ID: 25745483)
1. Desmopressin lyophilisate for the treatment of central diabetes insipidus: first experience in very young infants.
De Waele K; Cools M; De Guchtenaere A; Van de Walle J; Raes A; Van Aken S; De Coen K; Vanhaesebrouck P; De Schepper J
Int J Endocrinol Metab; 2014 Oct; 12(4):e16120. PubMed ID: 25745483
[TBL] [Abstract][Full Text] [Related]
2. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
3. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic effect of oral desmopressin lyophilisate formulation in children with central diabetes insipidus.
Korkmaz HA; Coşkunol F; Barışık V; Ozkan B
J Pediatr Endocrinol Metab; 2023 Oct; 36(10):925-929. PubMed ID: 37658767
[TBL] [Abstract][Full Text] [Related]
5. A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis.
Lottmann H; Froeling F; Alloussi S; El-Radhi AS; Rittig S; Riis A; Persson BE
Int J Clin Pract; 2007 Sep; 61(9):1454-60. PubMed ID: 17655682
[TBL] [Abstract][Full Text] [Related]
6. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
Ikeda H; Watanabe T; Isoyama K
Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
[TBL] [Abstract][Full Text] [Related]
7. The adverse effects of oral desmopressin lyophilisate (MELT): personal experience on enuretic children.
Ferrara P; Franceschini G; Mercurio S; Del Vescovo E; Ianniello F; Petitti T
Turk J Urol; 2018 Jan; 44(1):51-55. PubMed ID: 29484228
[TBL] [Abstract][Full Text] [Related]
8. Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis.
Michelet R; Dossche L; Van Herzeele C; Van Bocxlaer J; Vermeulen A; Vande Walle J;
Eur J Clin Pharmacol; 2018 Mar; 74(3):297-305. PubMed ID: 29198064
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of two sublingual types of desmopressin in 6-year-old and more children with primary nocturnal enuresis. About an international randomized cross-over study].
Lottmann H
Prog Urol; 2009 Feb; 19(2):132-8. PubMed ID: 19168019
[TBL] [Abstract][Full Text] [Related]
10. Plasma pharmacokinetics of desmopressin following sublingual administration: an exploratory dose-escalation study in healthy male volunteers.
Steiner IM; Kaehler ST; Sauermann R; Rinösl H; Müller M; Joukhadar C
Int J Clin Pharmacol Ther; 2006 Apr; 44(4):172-9. PubMed ID: 16625986
[TBL] [Abstract][Full Text] [Related]
11. Oral desmopressin lyophilisate (MELT) for monosymptomatic enuresis: structured versus abrupt withdrawal.
Ferrara P; Romano V; Cortina I; Ianniello F; Fabrizio GC; Chiaretti A
J Pediatr Urol; 2014 Feb; 10(1):52-5. PubMed ID: 23791016
[TBL] [Abstract][Full Text] [Related]
12. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
Van de Walle J; Van Herzeele C; Raes A
Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus.
Mavinkurve M; McGrath N; Johnston N; Moloney S; Murphy NP; Hawkes CP
J Pediatr Endocrinol Metab; 2017 May; 30(6):623-628. PubMed ID: 28599389
[TBL] [Abstract][Full Text] [Related]
14. Central diabetes insipidus is not a common and prognostically worse type of hypernatremia in neurointensive care.
Spatenkova V; Bradac O; Kazda A; Suchomel P
Neuro Endocrinol Lett; 2011; 32(6):879-84. PubMed ID: 22286785
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with desmopressin: efficacy and safety in central diabetes insipidus and other conditions.
Harris AS
J Pediatr; 1989 Apr; 114(4 Pt 2):711-8. PubMed ID: 2647953
[TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetic Modeling of a Desmopressin Oral Lyophilisate in Growing Piglets as a Model for the Pediatric Population.
Gasthuys E; Vermeulen A; Croubels S; Millecam J; Schauvliege S; van Bergen T; De Bruyne P; Vande Walle J; Devreese M
Front Pharmacol; 2018; 9():41. PubMed ID: 29445339
[TBL] [Abstract][Full Text] [Related]
17. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
Önol FF; Guzel R; Tahra A; Kaya C; Boylu U
J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
[TBL] [Abstract][Full Text] [Related]
18. Desmopressin acetate for enuresis and diabetes insipidus.
Cuomo O; Tafuro L; Del Gado R
Expert Rev Endocrinol Metab; 2006 Sep; 1(5):581-586. PubMed ID: 30754092
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin orally disintegrating tablet in Japanese patients with central diabetes insipidus: a retrospective study of switching from intranasal desmopressin.
Murakami T; Hatoko T; Nambu T; Matsuda Y; Matsuo K; Yonemitsu S; Muro S; Oki S
Endocr J; 2014; 61(8):773-9. PubMed ID: 24849384
[TBL] [Abstract][Full Text] [Related]
20. Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents.
Stenberg A; Läckgren G
Pediatrics; 1994 Dec; 94(6 Pt 1):841-6. PubMed ID: 7970999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
